Indonesia, Malaysia, Vietnam, Thailand, Philippines, Australia, New Zealand, China, Korea, and India Veterinary Medicine Market – Industry Trends and Forecast to 2030

Request for TOC طلب جدول المحتويات Speak to Analyst تحدث إلى المحلل Buy Now اشتري الآن Inquire Before Buying استفسر قبل Free Sample Report تقرير عينة مجاني

Indonesia, Malaysia, Vietnam, Thailand, Philippines, Australia, New Zealand, China, Korea, and India Veterinary Medicine Market – Industry Trends and Forecast to 2030

  • Pharmaceutical
  • Published Report
  • Jun 2023
  • Country Level
  • 350 الصفحات
  • عدد الجداول: 270
  • عدد الأرقام: 329

Indonesia Malaysia Vietnam Thailand Philippines Australia New Zealand China Korea And India Veterinary Medicine Market

حجم السوق بالمليار دولار أمريكي

CAGR :  % Diagram

Diagram فترة التنبؤ
2023 –2030
Diagram حجم السوق (السنة الأساسية)
مليون دولار أمريكي
Diagram حجم السوق (سنة التنبؤ)
USD 6,811.52
Diagram CAGR
%
Diagram Major Markets Players
  • Dummy1
  • Dummy2
  • Dummy3
  • Dummy4
  • Dummy5

Indonesia, Malaysia, Vietnam, Thailand, Philippines, Australia, New Zealand, China, Korea, and India Veterinary Medicine Market, By Product (Vaccines, Medication, and Supplements), Animal Type (Food Production and Companion Animals), Dosage (Solid, Liquid, and Semi-Solid), Route of Administration (Oral, Parenteral, and Topical), Application (Foot and Mouth Disease, Autoimmune Diseases, Bacterial Diseases, Helminthes Infection, Bluetongue, Canine Atopic Dermatitis, and Others), End User (Hospitals, Veterinary Clinics, Homecare Settings, and Laboratories), Distribution Channel (Direct Tender, Retail Sales, Online Pharmacy, and Others) - Industry Trends and Forecast to 2030.

Indonesia, Malaysia, Vietnam, Thailand, Philippines, Australia, New Zealand, China, Korea, and India Veterinary Medicine Market Analysis and Size

Indonesia, Malaysia, Vietnam, Thailand, Philippines, Australia, New Zealand, China, Korea, and India veterinary medicine market is fragmented in nature, as it consists of many global players such as Zoetis Services LLC, Boehringer Ingelheim International GmbH., Virbac, Ceva, and Dechra Pharmaceuticals PLC. among others. The presence of these companies produces competitive prices for veterinary medicines across the region. Due to the presence of these players at regional and international levels, suppliers and manufacturers offer products with different specifications and characteristics in all budgets. The rising pet ownership and humanization of pets are driving the market growth. Additionally, the rising prevalence of animal diseases is expected to drive the market growth.

Indonesia, Malaysia, Vietnam, Thailand, Philippines, Australia, New Zealand, China, Korea, and India Veterinary Medicine MarketIndonesia, Malaysia, Vietnam, Thailand, Philippines, Australia, New Zealand, China, Korea, and India Veterinary Medicine Market

Data Bridge Market Research analyzes that, Indonesia, Malaysia, Vietnam, Thailand, Philippines, Australia, New Zealand, China, Korea, and India veterinary medicine market is expected to reach a value of USD 6,811.52 million by 2030, at a CAGR of 10.1% during the forecast period. This market report also covers pricing analysis and technological advancements in depth.

Report Metric

Details

Forecast Period

2023 to 2030

Base Year

2022

Historic Years

2021 (Customizable to 2015 - 2020)

Quantitative Units

Revenue in Million, Volumes in Units, Pricing in USD

Segments Covered

Product (Vaccines, Medication, and Supplements), Animal Type (Food Production and Companion Animals), Dosage (Solid, Liquid, and Semi-Solid), Route of Administration (Oral, Parenteral, and Topical), Application (Foot and Mouth Disease, Autoimmune Diseases, Bacterial Diseases, Helminthes Infection, Bluetongue, Canine Atopic Dermatitis, and Others), End User (Hospitals, Veterinary Clinics, Homecare Settings, and Laboratories), Distribution Channel (Direct Tender, Retail Sales, Online Pharmacy, and Others)

Countries Covered

India, Australia, China, Indonesia, Malaysia, New Zealand, Korea, Vietnam, Thailand, and Philippines

Market Players Covered

Zoetis Services LLC (U.S.), Boehringer Ingelheim International GmbH.(Germany), Virbac (France), Ceva (France), Dechra Pharmaceuticals PLC (England), HUVEPHARMA (Bulgaria), Phibro Animal Health Corporation (U.S.), Kemin Industries, Inc.(U.S.), Vetoquinol (France), Mankind Pharma (India), Indian Immunologicals Ltd.(India), ECO Animal Health Ltd (U.K.), Biologische Heilmittel Heel GmbH, Alivira Animal Health Limited, Jurox Pty Limited, Biogénesis Bagó (Germany), Bentoli (U.S.), Inovet (Hungary), MSD Animal Health (U.S.), Zovix Pharmaceuticals (India), and Valor Chemical Co., Ltd (China) among others

Market Definition

The veterinary medicines market refers to the industry that develops, produces, and sells medicines and other healthcare products for animals. This includes medicines for pets, livestock, and other animals. The market is driven by the increasing demand for animal healthcare services and products, and the growing awareness of the importance of animal health and welfare. The veterinary medicines market includes various products such as vaccines, antibiotics, parasiticides, and anti-inflammatory drugs. The market is also influenced by factors such as government regulations, advancements in technology, and the level of competition.

Indonesia, Malaysia, Vietnam, Thailand, Philippines, Australia, New Zealand, China, Korea, and India Veterinary Medicine Market Dynamics

This section deals with understanding the market drivers, advantages, opportunities, restraints, and challenges. All of this is discussed in detail below:

DRIVERS

Increasing Pet Ownership and Humanization of Pets

The experience of pet ownership exists across many cultures in the world. In many countries, such as India, China, Korea, Thailand, Vietnam, and Australia a majority of people live with pets. Pet ownership is increasing due to a combination of factors such as the desire for companionship, health benefits, changing attitudes towards pets, and increased disposable income. Pets provide companionship and emotional support, which is especially important for people who live alone or have limited social interactions. Studies have shown that pet ownership can have numerous health benefits, including lower blood pressure, reduced stress levels, and improved mental health. Thus, more people move to urban areas, they may feel isolated and disconnected from nature. Owning a pet can provide a sense of connection to the natural world and a source of comfort.

Again as disposable income increases, people may have more money to spend on pets and pet-related expenses such as food, toys, and healthcare. Attitudes towards pets have changed over time, with many people now viewing pets as members of the family rather than just animals. The rise of social media has also contributed to the popularity of pet ownership, with many people sharing photos and stories of their pets online and connecting with other pet owners. Similarly, the humanization of pets refers to the trend of treating pets as members of the family and providing them with the same level of care and attention as human family members. This includes providing high-quality food, healthcare, and grooming services, and treating pets as companions and sources of emotional support.

Thus, more people adopt pets, the overall demand for veterinary medicines increases to meet the needs of these pets. Pet owners are increasingly interested in preventive healthcare for their pets, which involves regular check-ups and vaccinations. This leads to an increased demand for veterinary medicines such as vaccines and flea and tick preventives. Overall, pet adoption leads to an increased demand for veterinary medicines as pet owners seek to provide their pets with the best possible care and treatment. This trend is expected to continue as pet ownership continues to grow and pet owners become more invested in their pets' health and well-being.

Growing Prevalence of Animal Diseases

Growing animal diseases are related to increasing veterinary medicines because as the number of animal diseases increases, the demand for effective treatments and preventative measures also increases. This leads to the development and production of more veterinary medicines to address the various diseases and conditions affecting animals.

The use of veterinary medicines is essential in managing and controlling animal diseases, and their effectiveness can help reduce the spread of diseases and improve animal health. Therefore, the increasing need for veterinary medicines is directly related to the growing number of animal diseases and the need for effective interventions to manage them.

For instance,

  • In December 2022, as per NCBI, Malaysia experienced an outbreak of Highly Pathogenic Avian Influenza (HPAI) 2021, which is a viral disease affecting birds. The outbreak resulted in the culling of thousands of birds, leading to a significant loss in the country's poultry industry
  • In September 2021, an article published in Springer Nature that in 2019, China experienced an outbreak of African Swine Fever (ASF), which is a highly contagious disease affecting pigs. The outbreak resulted in the culling of millions of pigs, leading to a significant loss in the country's pork industry

According to above instances, it can be concluded that the growing prevalence of animal diseases is driving the growth of Indonesia, Malaysia, Vietnam, Thailand, Philippines, Australia, New Zealand, China, Korea, and India veterinary medicine market in the forecast period.

Indonesia, Malaysia, Vietnam, Thailand, Philippines, Australia, New Zealand, China, Korea, and India Veterinary Medicine Market

OPPORTUNITY

 Development of Novel and Personalized Veterinary Medicines

The development of novel and personalized veterinary medicines presents a significant opportunity for the veterinary medicines market. Personalized veterinary medicine refers to the use of targeted therapies based on a specific animal's genetic makeup, medical history, and other factors. This approach allows for more precise and effective treatment, with fewer side effects. The development of personalized veterinary medicines is closely related to advances in genomics and other areas of biomedical research. These advances have enabled researchers to better understand the underlying causes of diseases in animals and to develop targeted therapies that address these causes. Furthermore, there is a growing demand for personalized veterinary medicines among pet owners and veterinarians.

This demand is driving innovation in the veterinary medicines market, with new products and therapies being developed to address a wide range of conditions. In addition, the development of personalized veterinary medicines is also driving growth in the animal diagnostics market. As more animals are diagnosed with specific diseases or conditions, there is an increasing need for diagnostic tests that can accurately identify these conditions. Overall, the development of novel and personalized veterinary medicines is creating significant opportunities for growth in the veterinary medicines market. As research and development continue to advance, we can expect to see continued innovation and growth in this important sector.

RESTRAINT / CHALLENGE

High Cost of Veterinary Medicines

High prices of veterinary medicines may limit the affordability of pet owners and farmers, leading to reduced demand for these medicines. This could result in lower revenues for veterinary medicine manufacturers and distributors. When pet owners or farmers cannot afford the high cost of veterinary medicines, they may not comply with the recommended treatment regimen. This could result in poor health outcomes for animals and reduced effectiveness of the medicine.

High prices of veterinary medicines may attract new entrants to the market who offer lower-priced alternatives. This could increase competition and reduce market share for existing manufacturers. High prices of veterinary medicines may attract regulatory scrutiny and lead to increased regulation of the market. This could increase costs for manufacturers and distributors, leading to higher prices for consumers. Overall, the high cost of veterinary medicines can limit the growth of the market by reducing demand, increasing competition, and attracting regulatory attention.

Post-COVID-19 Impact on the Indonesia, Malaysia, Vietnam, Thailand, Philippines, Australia, New Zealand, China, Korea, and India Veterinary Medicine Market

COVID-19 created a negative impact on the Indonesia, Malaysia, Vietnam, Thailand, Philippines, Australia, New Zealand, China, Korea, and India veterinary medicine market. The lockdown restriction led to the emergence of various challenges such as decreased transportation and communication facilities as well as decreased veterinary hospital visits, thereby delaying the treatment procedures.

The COVID-19 pandemic has impacted the market to an extent in negative manner. However, increasing government support and advancements in veterinary medicines and technology is expected to provide lucrative opportunities for market growth. Moreover, increasing partnerships, acquisitions, and collaboration among market players are expected to further fuel the market growth. Also, the growth was high since the market opened after COVID-19, and it is expected that there would be considerable growth in the sector. The market players are conducting multiple activities to improve veterinary medicines. With this, the companies will bring advancement and innovation to the market.

Recent Developments

  • In April 2023, MSD Animal Health received marketing authorization from European Commission for BOVILIS Nasalgen-C live vaccine for cattle. This has helped the company to establish its global presence in the market.
  • In September 2022, Zoetis Services LLC announced that it has completed the acquisition of Jurox, a privately held animal health company that develops, manufactures, and markets a wide range of veterinary medicines for treating livestock and companion animals.

Indonesia, Malaysia, Vietnam, Thailand, Philippines, Australia, New Zealand, China, Korea, and India Veterinary Medicine Market Scope

Indonesia, Malaysia, Vietnam, Thailand, Philippines, Australia, New Zealand, China, Korea, and India veterinary medicine market is segmented into seven notable segments based on product, animal type, dosage, route of administration, application, end user, and distribution channel. The growth amongst these segments will help you analyze meager growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Product

  • Vaccines
  • Medication
  • Supplements

Based on product, the market is segmented into vaccines, medication, and supplements.

Animal Type

  • Food Production
  • Companion Animals

Based on animal type, the market is segmented into food production and companion animals.

Dosage

  • Solid
  • Liquid
  • Semi-Solid

Based on dosage, the market is segmented into solid, liquid, and semi-solid.

Route of Administration

  • Oral
  • Parenteral
  • Topical

Based on route of administration, the market is segmented into oral, parenteral, and topical.

Application

  • Foot and Mouth Disease
  • Autoimmune Diseases
  • Bacterial Diseases
  • Helminthes Infection
  • Bluetongue
  • Canine Atopic Dermatitis
  • Others

Based on application, the market is segmented into foot and mouth disease, autoimmune diseases, bacterial diseases, helminthes infection, bluetongue, canine atopic dermatitis, and others.

End User

  • Hospitals
  • Veterinary Clinics
  • Homecare Settings
  • Laboratories

Based on end user, the market is segmented into hospitals, veterinary clinics, homecare settings, and laboratories.

Distribution Channel

  • Direct Tender
  • Retail Sales
  • Online Pharmacy
  • Others

Based on distribution channel, the market is segmented into direct tender, retail sales, online pharmacy, and others.

Indonesia, Malaysia, Vietnam, Thailand, Philippines, Australia, New Zealand, China, Korea, and India Veterinary Medicine Market

Indonesia, Malaysia, Vietnam, Thailand, Philippines, Australia, New Zealand, China, Korea, and India Veterinary Medicine Market Analysis/Insights

The Indonesia, Malaysia, Vietnam, Thailand, Philippines, Australia, New Zealand, China, Korea, and India veterinary medicine market is analyzed and market size insights and trends are provided by country, product, animal type, dosage, route of administration, application, end user and distribution channel as referenced above. The countries covered in this market report are India, Australia, China, Indonesia, Malaysia, New Zealand, Korea, Vietnam, Thailand, and Philippines. India is dominating the market with the largest market share. This share is attributable to the presence of key market players such as Zoetis Services LLC, Boehringer Ingelheim International GmbH., Virbac, Ceva, and Dechra Pharmaceuticals PLC. among others. Rising pet ownership and humanization of pets are anticipated to fuel the market growth during the forecast period in this region.

The country section of the report also provides individual market-impacting factors and changes in market regulation that impact the current and future trends of the market. Data points like downstream and upstream value chain analysis, technical trends, Porter’s five forces analysis, and case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, the impact of domestic tariffs, and trade routes are considered while providing forecast analysis of the country data.

Competitive Landscape and Indonesia, Malaysia, Vietnam, Thailand, Philippines, Australia, New Zealand, China, Korea, and India Veterinary Medicine Market Share Analysis

The Indonesia, Malaysia, Vietnam, Thailand, Philippines, Australia, New Zealand, China, Korea, and India veterinary medicine market competitive landscape provides details of the competitor. Details included are company overview, company financials, revenue generated, market potential, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, and application dominance. The above data points provided are only related to the companies' focus related to the market.

Some of the major market players operating in the Indonesia, Malaysia, Vietnam, Thailand, Philippines, Australia, New Zealand, China, Korea, and India veterinary medicine market are Zoetis Services LLC (U.S.), Boehringer Ingelheim International GmbH.(Germany), Virbac (France), Ceva (France), Dechra Pharmaceuticals PLC (England), HUVEPHARMA (Bulgaria), Phibro Animal Health Corporation (U.S.), Kemin Industries, Inc.(U.S.), Vetoquinol (France), Mankind Pharma (India), Indian Immunologicals Ltd.(India), ECO Animal Health Ltd (U.K.), Biologische Heilmittel Heel GmbH, Alivira Animal Health Limited, Jurox Pty Limited, Biogénesis Bagó (Germany), Bentoli (U.S.), Inovet (Hungary), MSD Animal Health (U.S.), Zovix Pharmaceuticals (India), and Valor Chemical Co., Ltd (China) among others.


SKU-

احصل على إمكانية الوصول عبر الإنترنت إلى التقرير الخاص بأول سحابة استخبارات سوقية في العالم

  • لوحة معلومات تحليل البيانات التفاعلية
  • لوحة معلومات تحليل الشركة للفرص ذات إمكانات النمو العالية
  • إمكانية وصول محلل الأبحاث للتخصيص والاستعلامات
  • تحليل المنافسين باستخدام لوحة معلومات تفاعلية
  • آخر الأخبار والتحديثات وتحليل الاتجاهات
  • استغل قوة تحليل المعايير لتتبع المنافسين بشكل شامل
Request for Demo

Table of Content

1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY

1.2 MARKET DEFINITION

1.3 CURRENCY AND PRICING

1.4 LIMITATIONS

1.5 MARKETS COVERED

2 MARKET SEGMENTATION

2.1 MARKETS COVERED

2.2 GEOGRAPHICAL SCOPE

2.3 YEARS CONSIDERED FOR THE STUDY

2.4 DBMR TRIPOD DATA VALIDATION MODEL

2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS

2.6 MULTIVARIATE MODELLING

2.7 PRODUCT SEGMENT LIFELINE CURVE

2.8 MARKET END USER COVERAGE GRID

2.9 DBMR MARKET POSITION GRID

2.1 SECONDARY SOURCES

2.11 ASSUMPTIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

4.1 PESTEL ANALYSIS

4.2 PORTER'S FIVE FORCES MODEL

5 INDUSTRY INSIGHTS

5.1 PATENT ANALYSIS

5.2 DRUG TREATMENT RATE BY MATURED MARKETS

5.3 DEMOGRAPHIC TRENDS: IMPACTS ON ALL INCIDENCE RATES

5.4 PATIENT FLOW DIAGRAM

5.5 KEY PRICING STRATEGIES

5.6 KEY PATIENT ENROLLMENT STRATEGIES

6 INDONESIA, MALAYSIA, VIETNAM, THAILAND, PHILIPPINES, AUSTRALIA, NEW ZEALAND, CHINA, KOREA, AND INDIA VETERINARY MEDICINE MARKET: REGULATIONS

7 MARKET OVERVIEW

7.1 DRIVERS

7.1.1 INCREASING PET OWNERSHIP AND HUMANIZATION OF PETS

7.1.2 GROWING PREVALENCE OF ANIMAL DISEASES

7.1.3 ADVANCEMENTS IN VETERINARY MEDICINE AND TECHNOLOGY

7.1.4 INCREASING GOVERNMENT INITIATIVES FOR ANIMAL HEALTH AND WELFARE

7.2 RESTRAINTS

7.2.1 HIGH COST OF VETERINARY MEDICINES

7.2.2 STRINGENT REGULATORY REQUIREMENTS FOR APPROVAL

7.3 OPPORTUNITIES

7.3.1 DEVELOPMENT OF NOVEL AND PERSONALIZED VETERINARY MEDICINES

7.3.2 INCREASING TREND TOWARDS PREVENTIVE HEALTHCARE FOR ANIMALS

7.3.3 RISING DEMAND FOR NATURAL AND HERBAL VETERINARY MEDICINES

7.4 CHALLENGES

7.4.1 LIMITED R&D FUNDING FOR VETERINARY MEDICINES

7.4.2 LACK OF SKILLED VETERINARY PROFESSIONALS

8 INDONESIA, MALAYSIA, VIETNAM, THAILAND, PHILIPPINES, AUSTRALIA, NEW ZEALAND, CHINA, KOREA, & INDIA VETERINARY MEDICINE MARKET, BY PRODUCT

8.1 OVERVIEW

8.2 VACCINES

8.2.1 LIVE ATTENUATED VACCINES

8.2.2 TOXOID VACCINES

8.2.3 RECOMBINANT VACCINES

8.2.4 INACTIVATED VACCINES

8.2.5 OTHERS

8.3 MEDICATION

8.3.1 ANTIBIOTICS

8.3.1.1 AMOXICILLIN

8.3.1.2 AMPICILLIN

8.3.1.3 LINCOMYCIN

8.3.1.4 COLISTIN

8.3.1.5 GENTAMICIN

8.3.1.6 TETRACYCLINE

8.3.1.7 DOXYCYCLINE

8.3.1.8 TYLOSIN

8.3.1.9 OTHERS

8.3.2 ANALGESICS

8.3.2.1 ANTI-INFLAMMATORY (NSAIDS)

8.3.2.2 ACETAMINOPHEN

8.3.2.3 FIROCOXIB

8.3.2.4 MELOXICAM

8.3.2.5 CARPROFEN

8.3.2.6 DERACOXIB

8.3.2.7 PHENYLBUTAZONE

8.3.2.8 OTHERS

8.3.2.9 OPIOIDS

8.3.2.10 MU AGONISTS

8.3.2.10.1 MORPHINE

8.3.2.10.2 OXYMORPHONE

8.3.2.10.3 METHADONE

8.3.2.10.4 MEPERIDINE

8.3.2.10.5 OTHERS

8.3.2.11 KAPPA AGONIST-MU ANTAGONIST

8.3.2.11.1 BUTORPHANOL

8.3.2.11.2 OTHERS

8.3.2.12 PARTIAL MU AGONIST

8.3.2.13 BUPRENORPHINE

8.3.2.14 OTHERS

8.3.3 PARASITICIDES

8.3.3.1 AMPROLIUM

8.3.3.2 BENZIMIDAZOLES

8.3.3.3 NITROIMIDAZOLES

8.3.3.4 ALBENDAZOLE

8.3.3.5 PIPERAZINE

8.3.3.6 DELTAMETHRIN

8.3.3.7 LEVAMISOLE

8.3.3.8 OTHERS

8.3.4 ANTIHISTAMINES

8.3.4.1 CETIRIZINE

8.3.4.2 BROMPHENIRAMINE

8.3.4.3 DIPHENHYDRAMINE

8.3.4.4 TERFENADINE

8.3.4.5 TRIMEPRAZINE

8.3.4.6 OTHERS

8.3.5 CORTICOSTEROIDS

8.3.5.1 PREDNISONE

8.3.5.2 PREDNISOLONE

8.3.5.3 DEXAMETHASON

8.3.5.4 OTHERS

8.3.6 ANTIBLOAT

8.3.6.1 DOCUSATE

8.3.6.2 SIMETHICONE

8.3.6.3 OTHERS

8.3.7 HORMONAL

8.3.7.1 EQUINE CHORIONIC GONADOTROPIN

8.3.7.2 CLOPROSTENOL

8.3.7.3 OXYTOCIN

8.3.7.4 OTHERS

8.4 SUPPLEMENTS

8.4.1 VITAMINS

8.4.2 MINERALS

8.4.3 MOLD INHIBITOR

8.4.4 TOXIN BINDER

8.4.5 FEED ACIDIFIERS

8.4.6 OTHERS

9 INDONESIA, MALAYSIA, VIETNAM,THAILAND, PHILIPPINES, AUSTRALIA, NEW ZEALAND, CHINA, KOREA, & INDIA VETERINARY MEDICINE MARKET, BY ANIMAL TYPE

9.1 OVERVIEW

9.2 FOOD PRODUCTION

9.2.1 POULTRY

9.2.2 CATTLE

9.2.3 SWINE

9.2.4 FISH

9.2.5 OTHERS

9.3 COMPANION ANIMALS

9.3.1 DOGS

9.3.2 CATS

9.3.3 HORSES

9.3.4 OTHERS

10 INDONESIA, MALAYSIA, VIETNAM, THAILAND, PHILIPPINES, AUSTRALIA, NEW ZEALAND, CHINA, KOREA & INDIA VETERINARY MEDICINE MARKET, BY DOSAGE

10.1 OVERVIEW

10.2 SOLID

10.2.1 TABLET

10.2.2 POWDER

10.2.3 OTHERS

10.3 LIQUID

10.3.1 SYRUP

10.3.2 SUSPENSION

10.3.3 SOLUTION

10.3.4 BOLUS

10.3.5 OTHERS

10.4 SEMI-SOLID

10.4.1 GEL

10.4.2 CREAM

10.4.3 OTHERS

11 INDONESIA, MALAYSIA, VIETNAM, THAILAND, PHILIPPINES, AUSTRALIA, NEW ZEALAND, CHINA, KOREA & INDIA VETERINARY MEDICINE MARKET, BY ROUTE OF ADMINISTRATION

11.1 OVERVIEW

11.2 ORAL

11.3 PARENTERAL

11.4 TOPICAL

12 INDONESIA, MALAYSIA, VIETNAM,THAILAND, PHILIPPINES, AUSTRALIA, NEW ZEALAND, CHINA, KOREA, & INDIA VETERINARY MEDICINE MARKET, BY APPLICATION

12.1 OVERVIEW

12.2 FOOT AND MOUTH DISEASE

12.3 AUTOIMMUNE DISEASES

12.4 BACTERIAL DISEASES

12.5 HELMINTHES INFECTION

12.6 BLUETONGUE

12.7 CANINE ATOPIC DERMATITIS

12.8 OTHERS

13 INDONESIA, MALAYSIA, VIETNAM, THAILAND, PHILIPPINES, AUSTRALIA, NEW ZEALAND, CHINA, KOREA & INDIA VETERINARY MEDICINE MARKET, BY END USER

13.1 OVERVIEW

13.2 HOSPITALS

13.3 VETERINARY CLINICS

13.4 HOMECARE SETTINGS

13.5 LABORATORIES

14 INDONESIA, MALAYSIA, VIETNAM,THAILAND, PHILIPPINES, AUSTRALIA, NEW ZEALAND, CHINA, KOREA, & INDIA VETERINARY MEDICINE MARKET, BY DISTRIBUTION CHANNEL

14.1 OVERVIEW

14.2 DIRECT TENDER

14.3 RETAIL SALES

14.4 ONLINE PHARMACY

14.5 OTHERS

15 INDONESIA, MALAYSIA, VIETNAM, THAILAND, PHILIPPINES, AUSTRALIA, NEW ZEALAND, CHINA, KOREA, AND INDIA VETERINARY MEDICINE MARKET: COMPANY LANDSCAPE

15.1 COMPANY SHARE ANALYSIS: INDIA

15.2 COMPANY SHARE ANALYSIS: AUSTRALIA

15.3 COMPANY SHARE ANALYSIS: CHINA

15.4 COMPANY SHARE ANALYSIS: INDONESIA

15.5 COMPANY SHARE ANALYSIS: MALAYSIA

15.6 COMPANY SHARE ANALYSIS: NEW ZEALAND

15.7 COMPANY SHARE ANALYSIS: KOREA

15.8 COMPANY SHARE ANALYSIS: VIETNAM

15.9 COMPANY SHARE ANALYSIS: THAILAND

15.1 COMPANY SHARE ANALYSIS: PHILIPPINES

16 COMPANY PROFILE

16.1 ZOETIS SERVICES LLC

16.1.1 COMPANY SNAPSHOT

16.1.2 REVENUE ANALYSIS

16.1.3 PRODUCT PORTFOLIO

16.1.4 RECENT DEVELOPMENTS

16.2 BOEHRINGER INGELHEIM INTERNATIONAL GMBH

16.2.1 COMPANY SNAPSHOT

16.2.2 REVENUE ANALYSIS

16.2.3 PRODUCT PORTFOLIO

16.2.4 RECENT DEVELOPMENT

16.3 VIRBAC.

16.3.1 COMPANY SNAPSHOT

16.3.2 REVENUE ANALYSIS

16.3.3 PRODUCT PORTFOLIO

16.3.4 RECENT DEVELOPMENT

16.4 CEVA

16.4.1 COMPANY SNAPSHOT

16.4.2 PRODUCT PORTFOLIO

16.4.3 RECENT DEVELOPMENTS

16.5 DECHRA PHARMACEUTICALS PLC

16.5.1 COMPANY SNAPSHOT

16.5.2 REVENUE ANALYSIS

16.5.3 PRODUCT PORTFOLIO

16.5.4 RECENT DEVELOPMENT

16.6 ALIVIRA ANIMAL HEALTH LIMITED

16.6.1 COMPANY SNAPSHOT

16.6.2 PRODUCT PORTFOLIO

16.6.3 RECENT DEVELOPMENT

16.7 BENTOLI

16.7.1 COMPANY SNAPSHOT

16.7.2 PRODUCT PORTFOLIO

16.7.3 RECENT DEVELOPMENT

16.8 BIOGÉNESIS BAGÓ

16.8.1 COMPANY SNAPSHOT

16.8.2 PRODUCT PORTFOLIO

16.8.3 RECENT DEVELOPMENT

16.9 BIOLOGISCHE HEILMITTEL HEEL GMBH

16.9.1 COMPANY SNAPSHOT

16.9.2 PRODUCT PORTFOLIO

16.9.3 RECENT DEVELOPMENT

16.1 ECO ANIMAL HEALTH LTD

16.10.1 COMPANY SNAPSHOT

16.10.2 PRODUCT PORTFOLIO

16.10.3 RECENT DEVELOPMENTS

16.11 HUVEPHARMA

16.11.1 COMPANY SNAPSHOT

16.11.2 PRODUCT PORTFOLIO

16.11.3 RECENT DEVELOPMENT

16.12 INDIAN IMMUNOLOGICALS LTD.

16.12.1 COMPANY SNAPSHOT

16.12.2 PRODUCT PORTFOLIO

16.12.3 RECENT DEVELOPMENTS

16.13 INOVET

16.13.1 COMPANY SNAPSHOT

16.13.2 PRODUCT PORTFOLIO

16.13.3 RECENT DEVELOPMENTS

16.14 JUROX PTY LIMITED.

16.14.1 COMPANY SNAPSHOT

16.14.2 PRODUCT PORTFOLIO

16.14.3 RECENT DEVELOPMENT

16.15 KEMIN INDUSTRIES, INC.

16.15.1 COMPANY SNAPSHOT

16.15.2 PRODUCT PORTFOLIO

16.15.3 RECENT DEVELOPMENT

16.16 MANKIND PHARMA

16.16.1 COMPANY SNAPSHOT

16.16.2 REVENUE ANALYSIS

16.16.3 PRODUCT PORTFOLIO

16.16.4 RECENT DEVELOPMENT

16.17 MSD ANIMAL HEALTH

16.17.1 COMPANY SNAPSHOT

16.17.2 PRODUCT PORTFOLIO

16.17.3 RECENT DEVELOPMENTS

16.18 PHIBRO ANIMAL HEALTH CORPORATION.

16.18.1 COMPANY SNAPSHOT

16.18.2 REVENUE ANALYSIS

16.18.3 PRODUCT PORTFOLIO

16.18.4 RECENT DEVELOPMENT

16.19 VALOR CHEMICAL CO., LTD

16.19.1 COMPANY SNAPSHOT

16.19.2 PRODUCT PORTFOLIO

16.19.3 RECENT DEVELOPMENT

16.2 VETOQUINOL

16.20.1 COMPANY SNAPSHOT

16.20.2 PRODUCT PORTFOLIO

16.20.3 RECENT DEVELOPMENT

16.21 ZOVIX PHARMACEUTICALS.

16.21.1 COMPANY SNAPSHOT

16.21.2 PRODUCT PORTFOLIO

16.21.3 RECENT DEVELOPMENT

17 QUESTIONNAIRE

18 RELATED REPORTS

List of Table

TABLE 1 INDIA VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 2 AUSTRALIA VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 3 CHINA VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 4 INDONESIA VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 5 MALAYSIA VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 6 NEW ZEALAND VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 7 KOREA VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 8 VIETNAM VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 9 THAILAND VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 10 PHILIPPINES VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 11 INDIA VACCINES IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 12 AUSTRALIA VACCINES IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 13 CHINA VACCINES IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 14 INDONESIA VACCINES IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 15 MALAYSIA VACCINES IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 16 NEW ZEALAND VACCINES IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 17 KOREA VACCINES IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 18 VIETNAM VACCINES IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 19 THAILAND VACCINES IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 20 PHILIPPINES VACCINES IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 21 INDIA MEDICATIONS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 22 AUSTRALIA MEDICATIONS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 23 CHINA MEDICATIONS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 24 INDONESIA MEDICATIONS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 25 MALAYSIA MEDICATIONS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 26 NEW ZEALAND MEDICATIONS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 27 KOREA MEDICATIONS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 28 VIETNAM MEDICATIONS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 29 THAILAND MEDICATIONS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 30 PHILIPPINES MEDICATIONS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 31 INDIA ANTIBIOTICS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 32 AUSTRALIA ANTIBIOTICS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 33 CHINA ANTIBIOTICS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 34 INDONESIA ANTIBIOTICS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 35 MALAYSIA ANTIBIOTICS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 36 NEW ZEALAND ANTIBIOTICS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 37 KOREA ANTIBIOTICS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 38 VIETNAM ANTIBIOTICS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 39 THAILAND ANTIBIOTICS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 40 PHILIPPINES ANTIBIOTICS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 41 INDIA ANALGESICS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 42 AUSTRALIA ANALGESICS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 43 CHINA ANALGESICS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 44 INDONESIA ANALGESICS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 45 MALAYSIA ANALGESICS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 46 NEW ZEALAND ANALGESICS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 47 KOREA ANALGESICS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 48 VIETNAM ANALGESICS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 49 THAILAND ANALGESICS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 50 PHILIPPINES ANALGESICS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 51 INDIA ANTI-INFLAMMATORY (NSAIDS) IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 52 AUSTRALIA ANTI-INFLAMMATORY (NSAIDS) IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 53 CHINA ANTI-INFLAMMATORY (NSAIDS) IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 54 INDONESIA ANTI-INFLAMMATORY (NSAIDS) IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 55 MALAYSIA ANTI-INFLAMMATORY (NSAIDS) IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 56 NEW ZEALAND ANTI-INFLAMMATORY (NSAIDS) IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 57 KOREA ANTI-INFLAMMATORY (NSAIDS) IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 58 VIETNAM ANTI-INFLAMMATORY (NSAIDS) IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 59 THAILAND ANTI-INFLAMMATORY (NSAIDS) IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 60 PHILIPPINES ANTI-INFLAMMATORY (NSAIDS) IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 61 INDIA OPIOIDS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 62 AUSTRALIA OPIOIDS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 63 CHINA OPIOIDS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 64 INDONESIA OPIOIDS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 65 MALAYSIA OPIOIDS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 66 NEW ZEALAND OPIOIDS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 67 KOREA OPIOIDS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 68 VIETNAM OPIOIDS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 69 THAILAND OPIOIDS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 70 PHILIPPINES OPIOIDS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 71 INDIA MU AGONIST IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 72 AUSTRALIA MU AGONIST IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 73 CHINA MU AGONIST IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 74 INDONESIA MU AGONIST IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 75 MALAYSIA MU AGONIST IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 76 NEW ZEALAND MU AGONIST IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 77 KOREA MU AGONIST IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 78 VIETNAM MU AGONIST IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 79 THAILAND MU AGONIST IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 80 PHILIPPINES MU AGONIST IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 81 INDIA KAPPA AGONIST-MU ANTAGONIST IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 82 AUSTRALIA KAPPA AGONIST-MU ANTAGONIST S IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 83 CHINA KAPPA AGONIST-MU ANTAGONIST IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 84 INDONESIA KAPPA AGONIST-MU ANTAGONIST IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 85 MALAYSIA KAPPA AGONIST-MU ANTAGONIST IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 86 NEW ZEALAND KAPPA AGONIST-MU ANTAGONIST IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 87 KOREA KAPPA AGONIST-MU ANTAGONIST S IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 88 VIETNAM KAPPA AGONIST-MU ANTAGONIST IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 89 THAILAND KAPPA AGONIST-MU ANTAGONIST IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 90 PHILIPPINES KAPPA AGONIST-MU ANTAGONIST IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 91 INDIA PARTIAL MU AGONIST IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 92 AUSTRALIA PARTIAL MU AGONIST IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 93 CHINA PARTIAL MU AGONIST IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 94 INDONESIA PARTIAL MU AGONIST IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 95 MALAYSIA PARTIAL MU AGONIST IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 96 NEW ZEALAND PARTIAL MU AGONIST IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 97 KOREA PARTIAL MU AGONIST IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 98 VIETNAM PARTIAL MU AGONIST IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 99 THAILAND PARTIAL MU AGONIST IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 100 PHILIPPINES PARTIAL MU AGONIST IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 101 INDIA PARASITICIDES IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 102 AUSTRALIA PARASITICIDES IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 103 CHINA PARASITICIDES IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 104 INDONESIA PARASITICIDES IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 105 MALAYSIA PARASITICIDES IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 106 NEW ZEALAND PARASITICIDES IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 107 KOREA PARASITICIDES IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 108 VIETNAM PARASITICIDES IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 109 THAILAND PARASITICIDES IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 110 PHILIPPINES PARASITICIDES IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 111 INDIA ANTIHISTAMINES IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 112 AUSTRALIA ANTIHISTAMINES IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 113 CHINA ANTIHISTAMINES IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 114 INDONESIA ANTIHISTAMINES IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 115 MALAYSIA ANTIHISTAMINES IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 116 NEW ZEALAND ANTIHISTAMINES IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 117 KOREA ANTIHISTAMINES IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 118 VIETNAM ANTIHISTAMINES IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 119 THAILAND ANTIHISTAMINES IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 120 PHILIPPINES ANTIHISTAMINES IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 121 INDIA ANTIBIOTICS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 122 AUSTRALIA ANTIBIOTICS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 123 CHINA ANTIBIOTICS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 124 INDONESIA ANTIBIOTICS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 125 MALAYSIA ANTIBIOTICS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 126 NEW ZEALAND ANTIBIOTICS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 127 KOREA ANTIBIOTICS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 128 VIETNAM ANTIBIOTICS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 129 THAILAND ANTIBIOTICS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 130 PHILIPPINES ANTIBIOTICS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 131 INDIA ANTIBLOAT IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 132 AUSTRALIA ANTIBLOAT IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 133 CHINA ANTIBLOAT IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 134 INDONESIA ANTIBLOAT IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 135 MALAYSIA ANTIBLOAT IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 136 NEW ZEALAND ANTIBLOAT IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 137 KOREA ANTIBLOAT IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 138 VIETNAM ANTIBLOAT IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 139 THAILAND ANTIBLOAT IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 140 PHILIPPINES ANTIBLOAT IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 141 INDIA HORMONAL IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 142 AUSTRALIA HORMONAL IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 143 CHINA HORMONAL IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 144 INDONESIA HORMONAL IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 145 MALAYSIA HORMONAL IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 146 NEW ZEALAND HORMONAL IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 147 KOREA HORMONAL IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 148 VIETNAM HORMONAL IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 149 THAILAND HORMONAL IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 150 PHILIPPINES HORMONAL IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 151 INDIA SUPPLEMENTS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 152 AUSTRALIA SUPPLEMENTS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 153 CHINA SUPPLEMENTS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 154 INDONESIA SUPPLEMENTS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 155 MALAYSIA SUPPLEMENTS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 156 NEW ZEALAND SUPPLEMENTS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 157 KOREA SUPPLEMENTS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 158 VIETNAM SUPPLEMENTS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 159 THAILAND SUPPLEMENTS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 160 PHILIPPINES SUPPLEMENTS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 161 INDIA VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2021-2030 (USD MILLION)

TABLE 162 AUSTRALIA VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2021-2030 (USD MILLION)

TABLE 163 CHINA VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2021-2030 (USD MILLION)

TABLE 164 INDONESIA VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2021-2030 (USD MILLION)

TABLE 165 MALAYSIA VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2021-2030 (USD MILLION)

TABLE 166 NEW ZEALAND VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2021-2030 (USD MILLION)

TABLE 167 KOREA VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2021-2030 (USD MILLION)

TABLE 168 VIETNAM VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2021-2030 (USD MILLION)

TABLE 169 THAILAND VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2021-2030 (USD MILLION)

TABLE 170 PHILIPPINES VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2021-2030 (USD MILLION)

TABLE 171 INDIA FOOD PRODUCTION IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2021-2030 (USD MILLION)

TABLE 172 AUSTRALIA FOOD PRODUCTION IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2021-2030 (USD MILLION)

TABLE 173 CHINA FOOD PRODUCTION IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2021-2030 (USD MILLION)

TABLE 174 INDONESIA FOOD PRODUCTION IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2021-2030 (USD MILLION)

TABLE 175 MALAYSIA FOOD PRODUCTION IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2021-2030 (USD MILLION)

TABLE 176 NEW ZEALAND FOOD PRODUCTION IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2021-2030 (USD MILLION)

TABLE 177 KOREA FOOD PRODUCTION IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2021-2030 (USD MILLION)

TABLE 178 VIETNAM FOOD PRODUCTION IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2021-2030 (USD MILLION)

TABLE 179 THAILAND FOOD PRODUCTION IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2021-2030 (USD MILLION)

TABLE 180 PHILIPPINES FOOD PRODUCTION IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2021-2030 (USD MILLION)

TABLE 181 INDIA COMPANION ANIMALS IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2021-2030 (USD MILLION)

TABLE 182 AUSTRALIA COMPANION ANIMALS IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2021-2030 (USD MILLION)

TABLE 183 CHINA COMPANION ANIMALS IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2021-2030 (USD MILLION)

TABLE 184 INDONESIA COMPANION ANIMALS IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2021-2030 (USD MILLION)

TABLE 185 MALAYSIA COMPANION ANIMALS IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2021-2030 (USD MILLION)

TABLE 186 NEW ZEALAND COMPANION ANIMALS IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2021-2030 (USD MILLION)

TABLE 187 KOREA COMPANION ANIMALS IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2021-2030 (USD MILLION)

TABLE 188 VIETNAM COMPANION ANIMALS IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2021-2030 (USD MILLION)

TABLE 189 THAILAND  COMPANION ANIMALS IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2021-2030 (USD MILLION)

TABLE 190 PHILIPPINES COMPANION ANIMALS IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2021-2030 (USD MILLION)

TABLE 191 INDIA VETERINARY MEDICINE MARKET, BY DOSAGE, 2021-2030 (USD MILLION)

TABLE 192 AUSTRALIA VETERINARY MEDICINE MARKET, BY DOSAGE, 2021-2030 (USD MILLION)

TABLE 193 CHINA VETERINARY MEDICINE MARKET, BY DOSAGE, 2021-2030 (USD MILLION)

TABLE 194 INDONESIA VETERINARY MEDICINE MARKET, BY DOSAGE, 2021-2030 (USD MILLION)

TABLE 195 MALAYSIA VETERINARY MEDICINE MARKET, BY DOSAGE, 2021-2030 (USD MILLION)

TABLE 196 NEW ZEALAND VETERINARY MEDICINE MARKET, BY DOSAGE, 2021-2030 (USD MILLION)

TABLE 197 KOREA VETERINARY MEDICINE MARKET, BY DOSAGE, 2021-2030 (USD MILLION)

TABLE 198 VIETNAM VETERINARY MEDICINE MARKET, BY DOSAGE, 2021-2030 (USD MILLION)

TABLE 199 THAILAND VETERINARY MEDICINE MARKET, BY DOSAGE, 2021-2030 (USD MILLION)

TABLE 200 PHILIPPINES VETERINARY MEDICINE MARKET, BY DOSAGE, 2021-2030 (USD MILLION)

TABLE 201 INDIA SOLID IN VETERINARY MEDICINE MARKET, BY DOSAGE, 2021-2030 (USD MILLION)

TABLE 202 AUSTRALIA SOLID IN VETERINARY MEDICINE MARKET, BY DOSAGE, 2021-2030 (USD MILLION)

TABLE 203 CHINA SOLID IN VETERINARY MEDICINE MARKET, BY DOSAGE, 2021-2030 (USD MILLION)

TABLE 204 INDONESIA SOLID IN VETERINARY MEDICINE MARKET, BY DOSAGE, 2021-2030 (USD MILLION)

TABLE 205 MALAYSIA SOLID IN VETERINARY MEDICINE MARKET, BY DOSAGE, 2021-2030 (USD MILLION)

TABLE 206 NEW ZEALAND SOLID IN VETERINARY MEDICINE MARKET, BY DOSAGE, 2021-2030 (USD MILLION)

TABLE 207 KOREA SOLID IN VETERINARY MEDICINE MARKET, BY DOSAGE, 2021-2030 (USD MILLION)

TABLE 208 VIETNAM SOLID IN VETERINARY MEDICINE MARKET, BY DOSAGE, 2021-2030 (USD MILLION)

TABLE 209 THAILAND SOLID IN VETERINARY MEDICINE MARKET, BY DOSAGE, 2021-2030 (USD MILLION)

TABLE 210 PHILIPPINES SOLID IN VETERINARY MEDICINE MARKET, BY DOSAGE, 2021-2030 (USD MILLION)

TABLE 211 INDIA LIQUID IN VETERINARY MEDICINE MARKET, BY DOSAGE, 2021-2030 (USD MILLION)

TABLE 212 AUSTRALIA LIQUID IN VETERINARY MEDICINE MARKET, BY DOSAGE, 2021-2030 (USD MILLION)

TABLE 213 CHINA LIQUID IN VETERINARY MEDICINE MARKET, BY DOSAGE, 2021-2030 (USD MILLION)

TABLE 214 INDONESIA LIQUID IN VETERINARY MEDICINE MARKET, BY DOSAGE, 2021-2030 (USD MILLION)

TABLE 215 MALAYSIA LIQUID IN VETERINARY MEDICINE MARKET, BY DOSAGE, 2021-2030 (USD MILLION)

TABLE 216 NEW ZEALAND LIQUID IN VETERINARY MEDICINE MARKET, BY DOSAGE, 2021-2030 (USD MILLION)

TABLE 217 KOREA LIQUID IN VETERINARY MEDICINE MARKET, BY DOSAGE, 2021-2030 (USD MILLION)

TABLE 218 VIETNAM LIQUID IN VETERINARY MEDICINE MARKET, BY DOSAGE, 2021-2030 (USD MILLION)

TABLE 219 THAILAND LIQUID IN VETERINARY MEDICINE MARKET, BY DOSAGE, 2021-2030 (USD MILLION)

TABLE 220 PHILIPPINES LIQUID IN VETERINARY MEDICINE MARKET, BY DOSAGE, 2021-2030 (USD MILLION)

TABLE 221 INDIA SEMI-SOLID IN VETERINARY MEDICINE MARKET, BY DOSAGE, 2021-2030 (USD MILLION)

TABLE 222 AUSTRALIA SEMI-SOLID IN VETERINARY MEDICINE MARKET, BY DOSAGE, 2021-2030 (USD MILLION)

TABLE 223 CHINA SEMI-SOLID IN VETERINARY MEDICINE MARKET, BY DOSAGE, 2021-2030 (USD MILLION)

TABLE 224 INDONESIA SEMI-SOLID IN VETERINARY MEDICINE MARKET, BY DOSAGE, 2021-2030 (USD MILLION)

TABLE 225 MALAYSIA SEMI-SOLID IN VETERINARY MEDICINE MARKET, BY DOSAGE, 2021-2030 (USD MILLION)

TABLE 226 NEW ZEALAND SEMI-SOLID IN VETERINARY MEDICINE MARKET, BY DOSAGE, 2021-2030 (USD MILLION)

TABLE 227 KOREA SEMI-SOLID IN VETERINARY MEDICINE MARKET, BY DOSAGE, 2021-2030 (USD MILLION)

TABLE 228 VIETNAM SEMI-SOLID IN VETERINARY MEDICINE MARKET, BY DOSAGE, 2021-2030 (USD MILLION)

TABLE 229 THAILAND SEMI-SOLID IN VETERINARY MEDICINE MARKET, BY DOSAGE, 2021-2030 (USD MILLION)

TABLE 230 PHILIPPINES SEMI-SOLID IN VETERINARY MEDICINE MARKET, BY DOSAGE, 2021-2030 (USD MILLION)

TABLE 231 INDIA VETERINARY MEDICINE MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)

TABLE 232 AUSTRALIA VETERINARY MEDICINE MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)

TABLE 233 CHINA VETERINARY MEDICINE MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)

TABLE 234 INDONESIA VETERINARY MEDICINE MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)

TABLE 235 MALAYSIA VETERINARY MEDICINE MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)

TABLE 236 NEW ZEALAND VETERINARY MEDICINE MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)

TABLE 237 KOREA VETERINARY MEDICINE MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)

TABLE 238 VIETNAM VETERINARY MEDICINE MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)

TABLE 239 THAILAND VETERINARY MEDICINE MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)

TABLE 240 PHILIPPINES VETERINARY MEDICINE MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)

TABLE 241 INDIA VETERINARY MEDICINE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 242 AUSTRALIA VETERINARY MEDICINE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 243 CHINA VETERINARY MEDICINE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 244 INDONESIA VETERINARY MEDICINE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 245 MALAYSIA VETERINARY MEDICINE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 246 NEW ZEALAND VETERINARY MEDICINE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 247 KOREA VETERINARY MEDICINE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 248 VIETNAM VETERINARY MEDICINE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 249 THAILAND VETERINARY MEDICINE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 250 PHILIPPINES VETERINARY MEDICINE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 251 INDIA VETERINARY MEDICINE MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 252 AUSTRALIA VETERINARY MEDICINE MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 253 CHINA VETERINARY MEDICINE MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 254 INDONESIA VETERINARY MEDICINE MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 255 MALAYSIA VETERINARY MEDICINE MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 256 NEW ZEALAND VETERINARY MEDICINE MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 257 KOREA VETERINARY MEDICINE MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 258 VIETNAM VETERINARY MEDICINE MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 259 THAILAND VETERINARY MEDICINE MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 260 PHILIPPINES VETERINARY MEDICINE MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 261 INDIA VETERINARY MEDICINE MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 262 AUSTRALIA VETERINARY MEDICINE MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 263 CHINA VETERINARY MEDICINE MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 264 INDONESIA VETERINARY MEDICINE MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 265 MALAYSIA VETERINARY MEDICINE MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 266 NEW ZEALAND VETERINARY MEDICINE MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 267 KOREA VETERINARY MEDICINE MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 268 VIETNAM VETERINARY MEDICINE MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 269 THAILAND VETERINARY MEDICINE MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 270 PHILIPPINES VETERINARY MEDICINE MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

List of Figure

FIGURE 1 INDONESIA, MALAYSIA, VIETNAM, THAILAND, PHILIPPINES, AUSTRALIA, NEW ZEALAND, CHINA, KOREA, AND INDIA VETERINARY MEDICINE MARKET: SEGMENTATION

FIGURE 2 INDONESIA, MALAYSIA, VIETNAM, THAILAND, PHILIPPINES, AUSTRALIA, NEW ZEALAND, CHINA, KOREA, AND INDIA VETERINARY MEDICINE MARKET: DATA TRIANGULATION

FIGURE 3 INDONESIA, MALAYSIA, VIETNAM, THAILAND, PHILIPPINES, AUSTRALIA, NEW ZEALAND, CHINA, KOREA, AND INDIA VETERINARY MEDICINE MARKET: DROC ANALYSIS

FIGURE 4 INDIA VETERINARY MEDICINE MARKET: COUNTRY ANALYSIS

FIGURE 5 AUSTRALIA VETERINARY MEDICINE MARKET: COUNTRY ANALYSIS

FIGURE 6 CHINA VETERINARY MEDICINE MARKET: COUNTRY ANALYSIS

FIGURE 7 INDONESIA VETERINARY MEDICINE MARKET: COUNTRY ANALYSIS

FIGURE 8 MALAYSIA VETERINARY MEDICINE MARKET: COUNTRY ANALYSIS

FIGURE 9 NEW ZEALAND VETERINARY MEDICINE MARKET: COUNTRY ANALYSIS

FIGURE 10 KOREA VETERINARY MEDICINE MARKET: COUNTRY ANALYSIS

FIGURE 11 VIETNAM VETERINARY MEDICINE MARKET: COUNTRY ANALYSIS

FIGURE 12 THAILAND VETERINARY MEDICINE MARKET: COUNTRY ANALYSIS

FIGURE 13 PHILIPPINES VETERINARY MEDICINE MARKET: COUNTRY ANALYSIS

FIGURE 14 INDONESIA, MALAYSIA, VIETNAM, THAILAND, PHILIPPINES, AUSTRALIA, NEW ZEALAND, CHINA, KOREA, AND INDIA VETERINARY MEDICINE MARKET: COMPANY RESEARCH ANALYSIS

FIGURE 15 INDONESIA, MALAYSIA, VIETNAM, THAILAND, PHILIPPINES, AUSTRALIA, NEW ZEALAND, CHINA, KOREA, AND INDIA VETERINARY MEDICINE MARKET: INTERVIEW DEMOGRAPHICS

FIGURE 16 INDONESIA, MALAYSIA, VIETNAM, THAILAND, PHILIPPINES, AUSTRALIA, NEW ZEALAND, CHINA, KOREA, AND INDIA VETERINARY MEDICINE MARKET: MARKET END USER COVERAGE GRID

FIGURE 17 INDONESIA, MALAYSIA, VIETNAM, THAILAND, PHILIPPINES, AUSTRALIA, NEW ZEALAND, CHINA, KOREA, AND INDIA VETERINARY MEDICINE MARKET: DBMR MARKET POSITION GRID

FIGURE 18 INDONESIA, MALAYSIA, VIETNAM, THAILAND, PHILIPPINES, AUSTRALIA, NEW ZEALAND, CHINA, KOREA, AND INDIA VETERINARY MEDICINE MARKET: SEGMENTATION

FIGURE 19 RISING PET OWNERSHIP AND HUMANIZATION OF PET IS EXPECTED TO DRIVE THE GROWTH OF THE INDIA VETERINARY MEDICINE MARKET FROM 2023 TO 2030

FIGURE 20 GROWING PREVALENCE OF ANIMAL DISEASES IS EXPECTED TO DRIVE THE GROWTH OF AUSTRALIA VETERINARY MEDICINE MARKET FROM 2023 TO 2030

FIGURE 21 ADVANCEMENTS IN VETERINARY MEDICINE AND TECHNOLOGY IS EXPECTED TO DRIVE THE GROWTH OF CHINA VETERINARY MEDICINE MARKET FROM 2023 TO 2030

FIGURE 22 INCREASING GOVERNMENT INITIATIVES FOR ANIMAL HEALTH AND WELFARE IS EXPECTED TO DRIVE THE GROWTH OF INDONESIA VETERINARY MEDICINE MARKET FROM 2023 TO 2030

FIGURE 23 RISING PET OWNERSHIP AND HUMANIZATION OF PET IS EXPECTED TO DRIVE THE GROWTH OF MALAYSIA VETERINARY MEDICINE MARKET FROM 2023 TO 2030

FIGURE 24 GROWING PREVALENCE OF ANIMAL DISEASES IS EXPECTED TO DRIVE THE GROWTH OF NEW ZEALAND VETERINARY MEDICINE MARKET FROM 2023 TO 2030

FIGURE 25 ADVANCEMENTS IN VETERINARY MEDICINE AND TECHNOLOGY IS EXPECTED TO DRIVE THE GROWTH OF KOREA VETERINARY MEDICINE MARKET FROM 2023 TO 2030

FIGURE 26 INCREASING GOVERNMENT INITIATIVES FOR ANIMAL HEALTH AND WELFARE IS EXPECTED TO DRIVE THE GROWTH OF VIETNAM VETERINARY MEDICINE MARKET FROM 2023 TO 2030

FIGURE 27 RISING PET OWNERSHIP AND HUMANIZATION OF PET ARE EXPECTED TO DRIVE THE GROWTH OF THAILAND VETERINARY MEDICINE MARKET FROM 2023 TO 2030

FIGURE 28 THE GROWING PREVALENCE OF ANIMAL DISEASES IS EXPECTED TO DRIVE THE GROWTH OF PHILIPPINES VETERINARY MEDICINE MARKET FROM 2023 TO 2030

FIGURE 29 THE VACCINES SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF INDIA VETERINARY MEDICINE MARKET IN 2023 & 2030

FIGURE 30 THE VACCINES SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF AUSTRALIA VETERINARY MEDICINE MARKET IN 2023 & 2030

FIGURE 31 THE VACCINES SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF CHINA VETERINARY MEDICINE MARKET IN 2023 & 2030

FIGURE 32 THE VACCINES SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF INDONESIA VETERINARY MEDICINE MARKET IN 2023 & 2030

FIGURE 33 THE VACCINES SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF MALAYSIA VETERINARY MEDICINE MARKET IN 2023 & 2030

FIGURE 34 THE VACCINES SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF NEW ZEALAND VETERINARY MEDICINE MARKET IN 2023 & 2030

FIGURE 35 THE VACCINES SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF KOREA VETERINARY MEDICINE MARKET IN 2023 & 2030

FIGURE 36 THE VACCINES SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF VIETNAM VETERINARY MEDICINE MARKET IN 2023 & 2030

FIGURE 37 THE VACCINES SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THAILAND VETERINARY MEDICINE MARKET IN 2023 & 2030

FIGURE 38 THE VACCINES SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF VIETNAM VETERINARY MEDICINE MARKET IN 2023 & 2030

FIGURE 39 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE INDONESIA, MALAYSIA, VIETNAM, THAILAND, PHILIPPINES, AUSTRALIA, NEW ZEALAND, CHINA, KOREA, AND INDIA VETERINARY MEDICINE MARKET

FIGURE 40 INDIA VETERINARY MEDICINE MARKET: BY PRODUCT, 2022

FIGURE 41 AUSTRALIA VETERINARY MEDICINE MARKET: BY PRODUCT, 2022

FIGURE 42 CHINA VETERINARY MEDICINE MARKET: BY PRODUCT, 2022

FIGURE 43 INDONESIA VETERINARY MEDICINE MARKET: BY PRODUCT, 2022

FIGURE 44 MALAYSIA VETERINARY MEDICINE MARKET: BY PRODUCT, 2022

FIGURE 45 NEW ZEALAND VETERINARY MEDICINES MARKET: BY PRODUCT, 2022

FIGURE 46 KOREA VETERINARY MEDICINE MARKET: BY PRODUCT, 2022

FIGURE 47 VIETNAM VETERINARY MEDICINE MARKET: BY PRODUCT, 2022

FIGURE 48 THAILAND VETERINARY MEDICINES MARKET: BY PRODUCT, 2022

FIGURE 49 PHILIPPINES VETERINARY MEDICINES MARKET: BY PRODUCT, 2022

FIGURE 50 INDIA VETERINARY MEDICINE MARKET: BY PRODUCT, 2023-2030 (USD MILLION)

FIGURE 51 AUSTRALIA VETERINARY MEDICINE MARKET: BY PRODUCT, 2023-2030 (USD MILLION)

FIGURE 52 CHINA VETERINARY MEDICINE MARKET: BY PRODUCT, 2023-2030 (USD MILLION)

FIGURE 53 INDONESIA VETERINARY MEDICINE MARKET: BY PRODUCT, 2023-2030 (USD MILLION)

FIGURE 54 MALAYSIA VETERINARY MEDICINE MARKET: BY PRODUCT, 2023-2030 (USD MILLION)

FIGURE 55 NEW ZEALAND VETERINARY MEDICINE MARKET: BY PRODUCT, 2023-2030 (USD MILLION)

FIGURE 56 KOREA VETERINARY MEDICINE MARKET: BY PRODUCT, 2023-2030 (USD MILLION)

FIGURE 57 VIETNAM VETERINARY MEDICINE MARKET: BY PRODUCT, 2023-2030 (USD MILLION)

FIGURE 58 THAILAND VETERINARY MEDICINE MARKET: BY PRODUCT, 2023-2030 (USD MILLION)

FIGURE 59 PHILIPPINES VETERINARY MEDICINE MARKET: BY PRODUCT, 2023-2030 (USD MILLION)

FIGURE 60 INDIA VETERINARY MEDICINE MARKET: BY PRODUCT, CAGR (2023-2030)

FIGURE 61 AUSTRALIA VETERINARY MEDICINE MARKET: BY PRODUCT, CAGR (2023-2030)

FIGURE 62 CHINA VETERINARY MEDICINE MARKET: BY PRODUCT, CAGR (2023-2030)

FIGURE 63 INDONESIA VETERINARY MEDICINE MARKET: BY PRODUCT, CAGR (2023-2030)

FIGURE 64 MALAYSIA VETERINARY MEDICINE MARKET: BY PRODUCT, CAGR (2023-2030)

FIGURE 65 NEW ZEALAND VETERINARY MEDICINES MARKET: BY PRODUCT, CAGR (2023-2030)

FIGURE 66 KOREA VETERINARY MEDICINE MARKET: BY PRODUCT, CAGR (2023-2030)

FIGURE 67 VIETNAM VETERINARY MEDICINE MARKET: BY PRODUCT, CAGR (2023-2030)

FIGURE 68 THAILAND VETERINARY MEDICINES MARKET: BY PRODUCT, CAGR (2023-2030)

FIGURE 69 PHILIPPINES VETERINARY MEDICINE MARKET: BY PRODUCT, CAGR (2023-2030)

FIGURE 70 INDIA VETERINARY MEDICINE MARKET: BY PRODUCT, LIFELINE CURVE

FIGURE 71 AUSTRALIA VETERINARY MEDICINE MARKET: BY PRODUCT, LIFELINE CURVE

FIGURE 72 CHINA VETERINARY MEDICINE MARKET: BY PRODUCT, LIFELINE CURVE

FIGURE 73 INDONESIA VETERINARY MEDICINE MARKET: BY PRODUCT, LIFELINE CURVE

FIGURE 74 MALAYSIA VETERINARY MEDICINE MARKET: BY PRODUCT, LIFELINE CURVE

FIGURE 75 NEW ZEALAND VETERINARY MEDICINE MARKET: BY PRODUCT, LIFELINE CURVE

FIGURE 76 KOREA VETERINARY MEDICINE MARKET: BY PRODUCT, LIFELINE CURVE

FIGURE 77 VIETNAM VETERINARY MEDICINE MARKET: BY PRODUCT, LIFELINE CURVE

FIGURE 78 THAILAND VETERINARY MEDICINE MARKET: BY PRODUCT, LIFELINE CURVE

FIGURE 79 PHILIPPINES VETERINARY MEDICINE MARKET: BY PRODUCT, LIFELINE CURVE

FIGURE 80 INDIA VETERINARY MEDICINE MARKET: BY ANIMAL TYPE, 2022

FIGURE 81 AUSTRALIA VETERINARY MEDICINE MARKET: BY ANIMAL TYPE, 2022

FIGURE 82 CHINA VETERINARY MEDICINE MARKET: BY ANIMAL TYPE, 2022

FIGURE 83 INDONESIA VETERINARY MEDICINE MARKET: BY ANIMAL TYPE, 2022

FIGURE 84 MALAYSIA VETERINARY MEDICINE MARKET: BY ANIMAL TYPE, 2022

FIGURE 85 NEW ZEALAND VETERINARY MEDICINE MARKET: BY ANIMAL TYPE, 2022

FIGURE 86 KOREA VETERINARY MEDICINE MARKET: BY ANIMAL TYPE, 2022

FIGURE 87 VIETNAM VETERINARY MEDICINE MARKET: BY ANIMAL TYPE, 2022

FIGURE 88 THAILAND VETERINARY MEDICINE MARKET: BY ANIMAL TYPE, 2022

FIGURE 89 PHILIPPINES VETERINARY MEDICINE MARKET: BY ANIMAL TYPE, 2022

FIGURE 90 INDIA VETERINARY MEDICINE MARKET: BY ANIMAL TYPE, 2023-2030 (USD MILLION)

FIGURE 91 AUSTRALIA VETERINARY MEDICINE MARKET: BY ANIMAL TYPE, 2023-2030 (USD MILLION)

FIGURE 92 CHINA VETERINARY MEDICINE MARKET: BY ANIMAL TYPE, 2023-2030 (USD MILLION)

FIGURE 93 INDONESIA VETERINARY MEDICINE MARKET: BY ANIMAL TYPE, 2023-2030 (USD MILLION)

FIGURE 94 MALAYSIA VETERINARY MEDICINE MARKET: BY ANIMAL TYPE, 2023-2030 (USD MILLION)

FIGURE 95 NEW ZEALAND VETERINARY MEDICINE MARKET: BY ANIMAL TYPE, 2023-2030 (USD MILLION)

FIGURE 96 KOREA VETERINARY MEDICINE MARKET: BY ANIMAL TYPE, 2023-2030 (USD MILLION)

FIGURE 97 VIETNAM VETERINARY MEDICINE MARKET: BY ANIMAL TYPE, 2023-2030 (USD MILLION)

FIGURE 98 THAILAND VETERINARY MEDICINE MARKET: BY ANIMAL TYPE, 2023-2030 (USD MILLION)

FIGURE 99 PHILIPPINES VETERINARY MEDICINE MARKET: BY ANIMAL TYPE, 2023-2030 (USD MILLION)

FIGURE 100 INDIA VETERINARY MEDICINE MARKET: BY ANIMAL TYPE, CAGR (2023-2030)

FIGURE 101 AUSTRALIA VETERINARY MEDICINE MARKET: BY ANIMAL TYPE, CAGR (2023-2030)

FIGURE 102 CHINA VETERINARY MEDICINE MARKET: BY ANIMAL TYPE, CAGR (2023-2030)

FIGURE 103 INDONESIA VETERINARY MEDICINE MARKET: BY ANIMAL TYPE, CAGR (2023-2030)

FIGURE 104 MALAYSIA VETERINARY MEDICINE MARKET: BY ANIMAL TYPE, CAGR (2023-2030)

FIGURE 105 NEW ZEALAND VETERINARY MEDICINE MARKET: BY ANIMAL TYPE, CAGR (2023-2030)

FIGURE 106 KOREA VETERINARY MEDICINE MARKET: BY ANIMAL TYPE, CAGR (2023-2030)

FIGURE 107 VIETNAM VETERINARY MEDICINE MARKET: BY ANIMAL TYPE, CAGR (2023-2030)

FIGURE 108 THAILAND VETERINARY MEDICINE MARKET: BY ANIMAL TYPE, CAGR (2023-2030)

FIGURE 109 PHILIPPINES VETERINARY MEDICINE MARKET: BY ANIMAL TYPE, CAGR (2023-2030)

FIGURE 110 INDIA VETERINARY MEDICINE MARKET: BY ANIMAL TYPE, LIFELINE CURVE

FIGURE 111 AUSTRALIA VETERINARY MEDICINE MARKET: BY ANIMAL TYPE, LIFELINE CURVE

FIGURE 112 CHINA VETERINARY MEDICINE MARKET: BY ANIMAL TYPE, LIFELINE CURVE

FIGURE 113 INDONESIA VETERINARY MEDICINE MARKET: BY ANIMAL TYPE, LIFELINE CURVE

FIGURE 114 MALAYSIA VETERINARY MEDICINE MARKET: BY ANIMAL TYPE, LIFELINE CURVE

FIGURE 115 NEW ZEALAND VETERINARY MEDICINE MARKET: BY ANIMAL TYPE, LIFELINE CURVE

FIGURE 116 KOREA VETERINARY MEDICINE MARKET: BY ANIMAL TYPE, LIFELINE CURVE

FIGURE 117 VIETNAM VETERINARY MEDICINE MARKET: BY ANIMAL TYPE, LIFELINE CURVE

FIGURE 118 THAILAND VETERINARY MEDICINE MARKET: BY ANIMAL TYPE, LIFELINE CURVE

FIGURE 119 PHILIPPINES VETERINARY MEDICINE MARKET: BY ANIMAL TYPE, LIFELINE CURVE

FIGURE 120 INDIA VETERINARY MEDICINE MARKET: BY DOSAGE, 2022

FIGURE 121 AUSTRALIA VETERINARY MEDICINE MARKET: BY DOSAGE, 2022

FIGURE 122 CHINA VETERINARY MEDICINE MARKET: BY DOSAGE, 2022

FIGURE 123 INDONESIA VETERINARY MEDICINE MARKET: BY DOSAGE, 2022

FIGURE 124 MALAYSIA VETERINARY MEDICINE MARKET: BY DOSAGE, 2022

FIGURE 125 NEW ZEALAND VETERINARY MEDICINE MARKET: BY DOSAGE, 2022

FIGURE 126 KOREA VETERINARY MEDICINE MARKET: BY DOSAGE, 2022

FIGURE 127 VIETNAM VETERINARY MEDICINE MARKET: BY DOSAGE, 2022

FIGURE 128 THAILAND VETERINARY MEDICINE MARKET: BY DOSAGE, 2022

FIGURE 129 PHILIPPINES VETERINARY MEDICINE MARKET: BY DOSAGE, 2022

FIGURE 130 INDIA VETERINARY MEDICINE MARKET: BY DOSAGE, 2023-2030 (USD MILLION)

FIGURE 131 AUSTRALIA VETERINARY MEDICINE MARKET: BY DOSAGE, 2023-2030 (USD MILLION)

FIGURE 132 CHINA VETERINARY MEDICINE MARKET: BY DOSAGE, 2023-2030 (USD MILLION)

FIGURE 133 INDONESIA VETERINARY MEDICINE MARKET: BY DOSAGE, 2023-2030 (USD MILLION)

FIGURE 134 MALAYSIA VETERINARY MEDICINE MARKET: BY DOSAGE, 2023-2030 (USD MILLION)

FIGURE 135 NEW ZEALAND VETERINARY MEDICINE MARKET: BY DOSAGE, 2023-2030 (USD MILLION)

FIGURE 136 KOREA VETERINARY MEDICINE MARKET: BY DOSAGE, 2023-2030 (USD MILLION)

FIGURE 137 VIETNAM VETERINARY MEDICINE MARKET: BY DOSAGE, 2023-2030 (USD MILLION)

FIGURE 138 THAILAND VETERINARY MEDICINE MARKET: BY DOSAGE, 2023-2030 (USD MILLION)

FIGURE 139 PHILIPPINES VETERINARY MEDICINE MARKET: BY DOSAGE, 2023-2030 (USD MILLION)

FIGURE 140 INDIA VETERINARY MEDICINE MARKET: BY DOSAGE, CAGR (2023-2030)

FIGURE 141 AUSTRALIA VETERINARY MEDICINE MARKET: BY DOSAGE, CAGR (2023-2030)

FIGURE 142 CHINA VETERINARY MEDICINE MARKET: BY DOSAGE, CAGR (2023-2030)

FIGURE 143 INDONESIA IMMUNODIAGNOSTICS SMARKET: BY DOSAGE, CAGR (2023-2030)

FIGURE 144 MALAYSIA VETERINARY MEDICINE MARKET: BY DOSAGE, CAGR (2023-2030)

FIGURE 145 NEW ZEALAND VETERINARY MEDICINE MARKET: BY DOSAGE, CAGR (2023-2030)

FIGURE 146 KOREA VETERINARY MEDICINE MARKET: BY DOSAGE, CAGR (2023-2030)

FIGURE 147 VIETNAM VETERINARY MEDICINE MARKET: BY DOSAGE, CAGR (2023-2030)

FIGURE 148 THAILAND VETERINARY MEDICINE MARKET: BY DOSAGE, CAGR (2023-2030)

FIGURE 149 PHILIPPINES VETERINARY MEDICINE MARKET: BY DOSAGE, CAGR (2023-2030)

FIGURE 150 INDIA VETERINARY MEDICINE MARKET: BY DOSAGE, LIFELINE CURVE

FIGURE 151 AUSTRALIA VETERINARY MEDICINE MARKET: BY DOSAGE, LIFELINE CURVE

FIGURE 152 CHINA VETERINARY MEDICINE MARKET: BY DOSAGE, LIFELINE CURVE

FIGURE 153 INDONESIA VETERINARY MEDICINE MARKET: BY DOSAGE, LIFELINE CURVE

FIGURE 154 MALAYSIA VETERINARY MEDICINE MARKET: BY DOSAGE, LIFELINE CURVE

FIGURE 155 NEW ZEALAND VETERINARY MEDICINE MARKET: BY DOSAGE, LIFELINE CURVE

FIGURE 156 KOREA VETERINARY MEDICINE MARKET: BY DOSAGE, LIFELINE CURVE

FIGURE 157 VIETNAM VETERINARY MEDICINE MARKET: BY DOSAGE, LIFELINE CURVE

FIGURE 158 THAILAND VETERINARY MEDICINE MARKET: BY DOSAGE, LIFELINE CURVE

FIGURE 159 PHILIPPINES VETERINARY MEDICINE MARKET: BY DOSAGE, LIFELINE CURVE

FIGURE 160 INDIA VETERINARY MEDICINE MARKET: BY ROUTE OF ADMINISTRATION, 2022

FIGURE 161 AUSTRALIA VETERINARY MEDICINE MARKET: BY ROUTE OF ADMINISTRATION, 2022

FIGURE 162 CHINA VETERINARY MEDICINE MARKET: BY ROUTE OF ADMINISTRATION, 2022

FIGURE 163 INDONESIA VETERINARY MEDICINE MARKET: BY ROUTE OF ADMINISTRATION, 2022

FIGURE 164 MALAYSIA VETERINARY MEDICINE MARKET: BY ROUTE OF ADMINISTRATION, 2022

FIGURE 165 NEW ZEALAND VETERINARY MEDICINE MARKET: BY ROUTE OF ADMINISTRATION, 2022

FIGURE 166 KOREA VETERINARY MEDICINE MARKET: BY ROUTE OF ADMINISTRATION, 2022

FIGURE 167 VIETNAM VETERINARY MEDICINE MARKET: BY ROUTE OF ADMINISTRATION, 2022

FIGURE 168 THAILAND VETERINARY MEDICINE MARKET: BY ROUTE OF ADMINISTRATION, 2022

FIGURE 169 PHILIPPINES VETERINARY MEDICINE MARKET: BY ROUTE OF ADMINISTRATION, 2022

FIGURE 170 INDIA VETERINARY MEDICINE MARKET: BY ROUTE OF ADMINISTRATION, 2023-2030 (USD MILLION)

FIGURE 171 AUSTRALIA VETERINARY MEDICINE MARKET: BY ROUTE OF ADMINISTRATION, 2023-2030 (USD MILLION)

FIGURE 172 CHINA VETERINARY MEDICINE MARKET: BY ROUTE OF ADMINISTRATION, 2023-2030 (USD MILLION)

FIGURE 173 INDONESIA VETERINARY MEDICINE MARKET: BY ROUTE OF ADMINISTRATION, 2023-2030 (USD MILLION)

FIGURE 174 MALAYSIA VETERINARY MEDICINE MARKET: BY ROUTE OF ADMINISTRATION, 2023-2030 (USD MILLION)

FIGURE 175 NEW ZEALAND VETERINARY MEDICINE MARKET: BY ROUTE OF ADMINISTRATION, 2023-2030 (USD MILLION)

FIGURE 176 KOREA VETERINARY MEDICINE MARKET: BY ROUTE OF ADMINISTRATION, 2023-2030 (USD MILLION)

FIGURE 177 VIETNAM VETERINARY MEDICINE MARKET: BY ROUTE OF ADMINISTRATION, 2023-2030 (USD MILLION)

FIGURE 178 THAILAND VETERINARY MEDICINE MARKET: BY ROUTE OF ADMINISTRATION, 2023-2030 (USD MILLION)

FIGURE 179 PHILIPPINES VETERINARY MEDICINE MARKET: BY ROUTE OF ADMINISTRATION, 2023-2030 (USD MILLION)

FIGURE 180 INDIA VETERINARY MEDICINE MARKET: BY ROUTE OF ADMINISTRATION, CAGR (2023-2030)

FIGURE 181 AUSTRALIA VETERINARY MEDICINE MARKET: BY ROUTE OF ADMINISTRATION, CAGR (2023-2030)

FIGURE 182 CHINA VETERINARY MEDICINE MARKET: BY ROUTE OF ADMINISTRATION, CAGR (2023-2030)

FIGURE 183 INDONESIA IMMUNODIAGNOSTICS SMARKET: BY ROUTE OF ADMINISTRATION, CAGR (2023-2030)

FIGURE 184 MALAYSIA VETERINARY MEDICINE MARKET: BY ROUTE OF ADMINISTRATION, CAGR (2023-2030)

FIGURE 185 NEW ZEALAND VETERINARY MEDICINE MARKET: BY ROUTE OF ADMINISTRATION, CAGR (2023-2030)

FIGURE 186 KOREA VETERINARY MEDICINE MARKET: BY ROUTE OF ADMINISTRATION, CAGR (2023-2030)

FIGURE 187 VIETNAM VETERINARY MEDICINE MARKET: BY ROUTE OF ADMINISTRATION, CAGR (2023-2030)

FIGURE 188 THAILAND VETERINARY MEDICINE MARKET: BY ROUTE OF ADMINISTRATION, CAGR (2023-2030)

FIGURE 189 PHILIPPINES VETERINARY MEDICINE MARKET: BY ROUTE OF ADMINISTRATION, CAGR (2023-2030)

FIGURE 190 INDIA VETERINARY MEDICINE MARKET: BY ROUTE OF ADMINISTRATION, LIFELINE CURVE

FIGURE 191 AUSTRALIA VETERINARY MEDICINE MARKET: BY ROUTE OF ADMINISTRATION, LIFELINE CURVE

FIGURE 192 CHINA VETERINARY MEDICINE MARKET: BY ROUTE OF ADMINISTRATION, LIFELINE CURVE

FIGURE 193 INDONESIA VETERINARY MEDICINE MARKET: BY ROUTE OF ADMINISTRATION, LIFELINE CURVE

FIGURE 194 MALAYSIA VETERINARY MEDICINE MARKET: BY ROUTE OF ADMINISTRATION, LIFELINE CURVE

FIGURE 195 NEW ZEALAND VETERINARY MEDICINE MARKET: BY ROUTE OF ADMINISTRATION, LIFELINE CURVE

FIGURE 196 KOREA VETERINARY MEDICINE MARKET: BY ROUTE OF ADMINISTRATION, LIFELINE CURVE

FIGURE 197 VIETNAM VETERINARY MEDICINE MARKET: BY ROUTE OF ADMINISTRATION, LIFELINE CURVE

FIGURE 198 THAILAND VETERINARY MEDICINE MARKET: BY ROUTE OF ADMINISTRATION, LIFELINE CURVE

FIGURE 199 PHILIPPINES VETERINARY MEDICINE MARKET: BY ROUTE OF ADMINISTRATION, LIFELINE CURVE

FIGURE 200 INDIA VETERINARY MEDICINE MARKET: BY APPLICATION, 2022

FIGURE 201 AUSTRALIA VETERINARY MEDICINE MARKET: BY APPLICATION, 2022

FIGURE 202 CHINA VETERINARY MEDICINE MARKET: BY APPLICATION, 2022

FIGURE 203 INDONESIA VETERINARY MEDICINE MARKET: BY APPLICATION, 2022

FIGURE 204 MALAYSIA VETERINARY MEDICINE MARKET: BY APPLICATION, 2022

FIGURE 205 NEW ZEALAND VETERINARY MEDICINE MARKET: BY APPLICATION, 2022

FIGURE 206 KOREA VETERINARY MEDICINE MARKET: BY APPLICATION, 2022

FIGURE 207 VIETNAM VETERINARY MEDICINE MARKET: BY APPLICATION, 2022

FIGURE 208 THAILAND VETERINARY MEDICINE MARKET: BY APPLICATION, 2022

FIGURE 209 PHILIPPINES VETERINARY MEDICINE MARKET: BY APPLICATION, 2022

FIGURE 210 INDIA VETERINARY MEDICINE MARKET: BY APPLICATION, 2023-2030 (USD MILLION)

FIGURE 211 AUSTRALIA VETERINARY MEDICINE MARKET: BY APPLICATION, 2023-2030 (USD MILLION)

FIGURE 212 CHINA VETERINARY MEDICINE MARKET: BY APPLICATION, 2023-2030 (USD MILLION)

FIGURE 213 INDONESIA VETERINARY MEDICINE MARKET: BY APPLICATION, 2023-2030 (USD MILLION)

FIGURE 214 MALAYSIA VETERINARY MEDICINE MARKET: BY APPLICATION, 2023-2030 (USD MILLION)

FIGURE 215 NEW ZEALAND VETERINARY MEDICINE MARKET: BY APPLICATION, 2023-2030 (USD MILLION)

FIGURE 216 KOREA VETERINARY MEDICINE MARKET: BY APPLICATION, 2023-2030 (USD MILLION)

FIGURE 217 VIETNAM VETERINARY MEDICINE MARKET: BY APPLICATION, 2023-2030 (USD MILLION)

FIGURE 218 THAILAND VETERINARY MEDICINE MARKET: BY APPLICATION, 2023-2030 (USD MILLION)

FIGURE 219 PHILIPPINES VETERINARY MEDICINE MARKET: BY APPLICATION, 2023-2030 (USD MILLION)

FIGURE 220 INDIA VETERINARY MEDICINE MARKET: BY APPLICATION, CAGR (2023-2030)

FIGURE 221 AUSTRALIA VETERINARY MEDICINE MARKET: BY APPLICATION, CAGR (2023-2030)

FIGURE 222 CHINA VETERINARY MEDICINE MARKET: BY APPLICATION, CAGR (2023-2030)

FIGURE 223 INDONESIA VETERINARY MEDICINE MARKET: BY APPLICATION, CAGR (2023-2030)

FIGURE 224 MALAYSIA VETERINARY MEDICINE MARKET: BY APPLICATION, CAGR (2023-2030)

FIGURE 225 NEW ZEALAND VETERINARY MEDICINE MARKET: BY APPLICATION, CAGR (2023-2030)

FIGURE 226 KOREA VETERINARY MEDICINE MARKET: BY APPLICATION, CAGR (2023-2030)

FIGURE 227 VIETNAM VETERINARY MEDICINE MARKET: BY APPLICATION, CAGR (2023-2030)

FIGURE 228 THAILAND VETERINARY MEDICINE MARKET: BY APPLICATION, CAGR (2023-2030)

FIGURE 229 PHILIPPINES VETERINARY MEDICINE MARKET: BY APPLICATION, CAGR (2023-2030)

FIGURE 230 INDIA VETERINARY MEDICINE MARKET: BY APPLICATION, LIFELINE CURVE

FIGURE 231 ASUTRALIA VETERINARY MEDICINE MARKET: BY APPLICATION, LIFELINE CURVE

FIGURE 232 CHINA VETERINARY MEDICINE MARKET: BY APPLICATION, LIFELINE CURVE

FIGURE 233 INDONESIA VETERINARY MEDICINE MARKET: BY APPLICATION, LIFELINE CURVE

FIGURE 234 MALAYSIA VETERINARY MEDICINE MARKET: BY APPLICATION, LIFELINE CURVE

FIGURE 235 NEW ZEALAND VETERINARY MEDICINE MARKET: BY APPLICATION, LIFELINE CURVE

FIGURE 236 KOREA VETERINARY MEDICINE MARKET: BY APPLICATION, LIFELINE CURVE

FIGURE 237 VIETNAM VETERINARY MEDICINE MARKET: BY APPLICATION, LIFELINE CURVE

FIGURE 238 THAILAND VETERINARY MEDICINE MARKET: BY APPLICATION, LIFELINE CURVE

FIGURE 239 PHILIPPINES VETERINARY MEDICINE MARKET: BY APPLICATION, LIFELINE CURVE

FIGURE 240 INDIA VETERINARY MEDICINE MARKET: BY END USER, 2022

FIGURE 241 AUSTRALIA VETERINARY MEDICINE MARKET: BY END USER, 2022

FIGURE 242 CHINA VETERINARY MEDICINE MARKET: BY END USER, 2022

FIGURE 243 INDONESIA VETERINARY MEDICINE MARKET: BY END USER, 2022

FIGURE 244 MALAYSIA VETERINARY MEDICINE MARKET: BY END USER, 2022

FIGURE 245 NEW ZEALAND VETERINARY MEDICINE MARKET: BY END USER, 2022

FIGURE 246 KOREA VETERINARY MEDICINE MARKET: BY END USER, 2022

FIGURE 247 VIETNAM VETERINARY MEDICINE MARKET: BY END USER, 2022

FIGURE 248 THAILAND VETERINARY MEDICINE MARKET: BY END USER, 2022

FIGURE 249 PHILIPPINES VETERINARY MEDICINE MARKET: BY END USER, 2022

FIGURE 250 INDIA VETERINARY MEDICINE MARKET: BY END USER, 2023-2030 (USD MILLION)

FIGURE 251 AUSTRALIA VETERINARY MEDICINE MARKET: BY END USER, 2023-2030 (USD MILLION)

FIGURE 252 CHINA VETERINARY MEDICINE MARKET: BY END USER, 2023-2030 (USD MILLION)

FIGURE 253 INDONESIA VETERINARY MEDICINE MARKET: BY END USER, 2023-2030 (USD MILLION)

FIGURE 254 MALAYSIA VETERINARY MEDICINE MARKET: BY END USER, 2023-2030 (USD MILLION)

FIGURE 255 NEW ZEALAND VETERINARY MEDICINE MARKET: BY END USER, 2023-2030 (USD MILLION)

FIGURE 256 KOREA VETERINARY MEDICINE MARKET: BY END USER, 2023-2030 (USD MILLION)

FIGURE 257 VIETNAM VETERINARY MEDICINE MARKET: BY END USER, 2023-2030 (USD MILLION)

FIGURE 258 THAILAND VETERINARY MEDICINE MARKET: BY END USER, 2023-2030 (USD MILLION)

FIGURE 259 PHILIPPINES VETERINARY MEDICINE MARKET: BY END USER, 2023-2030 (USD MILLION)

FIGURE 260 INDIA VETERINARY MEDICINE MARKET: BY END USER, CAGR (2023-2030)

FIGURE 261 AUSTRALIA VETERINARY MEDICINE MARKET: BY END USER, CAGR (2023-2030)

FIGURE 262 CHINA VETERINARY MEDICINE MARKET: BY END USER, CAGR (2023-2030)

FIGURE 263 INDONESIA IMMUNODIAGNOSTICS SMARKET: BY END USER, CAGR (2023-2030)

FIGURE 264 MALAYSIA VETERINARY MEDICINE MARKET: BY END USER, CAGR (2023-2030)

FIGURE 265 NEW ZEALAND VETERINARY MEDICINE MARKET: BY END USER, CAGR (2023-2030)

FIGURE 266 KOREA VETERINARY MEDICINE MARKET: BY END USER, CAGR (2023-2030)

FIGURE 267 VIETNAM VETERINARY MEDICINE MARKET: BY END USER, CAGR (2023-2030)

FIGURE 268 THAILAND VETERINARY MEDICINE MARKET: BY END USER, CAGR (2023-2030)

FIGURE 269 PHILIPPINES VETERINARY MEDICINE MARKET: BY END USER, CAGR (2023-2030)

FIGURE 270 INDIA VETERINARY MEDICINE MARKET: BY END USER, LIFELINE CURVE

FIGURE 271 AUSTRALIA VETERINARY MEDICINE MARKET: BY END USER, LIFELINE CURVE

FIGURE 272 CHINA VETERINARY MEDICINE MARKET: BY END USER, LIFELINE CURVE

FIGURE 273 INDONESIA VETERINARY MEDICINE MARKET: BY END USER, LIFELINE CURVE

FIGURE 274 MALAYSIA VETERINARY MEDICINE MARKET: BY END USER, LIFELINE CURVE

FIGURE 275 NEW ZEALAND VETERINARY MEDICINE MARKET: BY END USER, LIFELINE CURVE

FIGURE 276 KOREA VETERINARY MEDICINE MARKET: BY END USER, LIFELINE CURVE

FIGURE 277 VIETNAM VETERINARY MEDICINE MARKET: BY END USER, LIFELINE CURVE

FIGURE 278 THAILAND VETERINARY MEDICINE MARKET: BY END USER, LIFELINE CURVE

FIGURE 279 PHILIPPINES VETERINARY MEDICINE MARKET: BY END USER, LIFELINE CURVE

FIGURE 280 INDIA VETERINARY MEDICINE MARKET: BY DISTRIBUTION CHANNEL, 2022

FIGURE 281 AUSTRALIA VETERINARY MEDICINE MARKET: BY DISTRIBUTION CHANNEL, 2022

FIGURE 282 CHINA VETERINARY MEDICINE MARKET: BY DISTRIBUTION CHANNEL, 2022

FIGURE 283 INDONESIA VETERINARY MEDICINE MARKET: BY DISTRIBUTION CHANNEL, 2022

FIGURE 284 MALAYSIA VETERINARY MEDICINE MARKET: BY DISTRIBUTION CHANNEL, 2022

FIGURE 285 NEW ZEALAND VETERINARY MEDICINE MARKET: BY DISTRIBUTION CHANNEL, 2022

FIGURE 286 KOREA VETERINARY MEDICINE MARKET: BY DISTRIBUTION CHANNEL ,2022

FIGURE 287 VIETNAM VETERINARY MEDICINE MARKET: BY DISTRIBUTION CHANNEL, 2022

FIGURE 288 THAILAND VETERINARY MEDICINE MARKET: BY DISTRIBUTION CHANNEL, 2022

FIGURE 289 PHILIPPINES VETERINARY MEDICINE MARKET: BY DISTRIBUTION CHANNEL, 2022

FIGURE 290 INDIA VETERINARY MEDICINE MARKET: BY DISTRIBUTION CHANNEL, 2023-2030 (USD MILLION)

FIGURE 291 AUSTRALIA VETERINARY MEDICINE MARKET: BY DISTRIBUTION CHANNEL, 2023-2030 (USD MILLION)

FIGURE 292 CHINA VETERINARY MEDICINE MARKET: BY DISTRIBUTION CHANNEL, 2023-2030 (USD MILLION)

FIGURE 293 INDONESIA VETERINARY MEDICINE MARKET: BY DISTRIBUTION CHANNEL, 2023-2030 (USD MILLION)

FIGURE 294 MALAYSIA VETERINARY MEDICINE MARKET: BY DISTRIBUTION CHANNEL, 2023-2030 (USD MILLION)

FIGURE 295 NEW ZEALAND VETERINARY MEDICINE MARKET: BY DISTRIBUTION CHANNEL, 2023-2030 (USD MILLION)

FIGURE 296 KOREA VETERINARY MEDICINE MARKET: BY DISTRIBUTION CHANNEL, 2023-2030 (USD MILLION)

FIGURE 297 VIETNAM VETERINARY MEDICINE MARKET: BY DISTRIBUTION CHANNEL, 2023-2030 (USD MILLION)

FIGURE 298 THAILAND VETERINARY MEDICINE MARKET: BY DISTRIBUTION CHANNEL, 2023-2030 (USD MILLION)

FIGURE 299 PHILIPPINES VETERINARY MEDICINE MARKET: BY DISTRIBUTION CHANNEL, 2023-2030 (USD MILLION)

FIGURE 300 INDIA VETERINARY MEDICINE MARKET: BY DISTRIBUTION CHANNEL, CAGR (2023-2030)

FIGURE 301 AUSTRALIA VETERINARY MEDICINE MARKET: BY DISTRIBUTION CHANNEL, CAGR (2023-2030)

FIGURE 302 CHINA VETERINARY MEDICINE MARKET: BY DISTRIBUTION CHANNEL, CAGR (2023-2030)

FIGURE 303 INDONESIA VETERINARY MEDICINE MARKET: BY DISTRIBUTION CHANNEL, CAGR (2023-2030)

FIGURE 304 MALAYSIA VETERINARY MEDICINE MARKET: BY DISTRIBUTION CHANNEL, CAGR (2023-2030)

FIGURE 305 NEW ZEALAND VETERINARY MEDICINE MARKET: BY DISTRIBUTION CHANNEL, CAGR (2023-2030)

FIGURE 306 KOREA VETERINARY MEDICINE MARKET: BY DISTRIBUTION CHANNEL, CAGR (2023-2030)

FIGURE 307 VIETNAM VETERINARY MEDICINE MARKET: BY DISTRIBUTION CHANNEL, CAGR (2023-2030)

FIGURE 308 THAILAND VETERINARY MEDICINE MARKET: BY DISTRIBUTION CHANNEL, CAGR (2023-2030)

FIGURE 309 PHILIPPINES VETERINARY MEDICINE MARKET: BY DISTRIBUTION CHANNEL, CAGR (2023-2030)

FIGURE 310 INDIA VETERINARY MEDICINE MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE

FIGURE 311 ASUTRALIA VETERINARY MEDICINE MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE

FIGURE 312 CHINA VETERINARY MEDICINE MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE

FIGURE 313 INDONESIA VETERINARY MEDICINE MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE

FIGURE 314 MALAYSIA VETERINARY MEDICINE MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE

FIGURE 315 NEW ZEALAND VETERINARY MEDICINE MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE

FIGURE 316 KOREA VETERINARY MEDICINE MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE

FIGURE 317 VIETNAM VETERINARY MEDICINE MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE

FIGURE 318 THAILAND VETERINARY MEDICINE MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE

FIGURE 319 PHILIPPINES VETERINARY MEDICINE MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE

FIGURE 320 INDIA VETERINARY MARKET: COMPANY SHARE 2022 (%)

FIGURE 321 AUSTRALIA VETERINARY MARKET: COMPANY SHARE 2022 (%)

FIGURE 322 CHINA VETERINARY MEDICINE MARKET: COMPANY SHARE 2022 (%)

FIGURE 323 INDONESIA VETERINARY MEDICINE MARKET: COMPANY SHARE 2022 (%)

FIGURE 324 MALAYSIA VETERINARY MEDICINE MARKET: COMPANY SHARE 2022 (%)

FIGURE 325 NEW ZEALAND VETERINARY MEDICINE MARKET: COMPANY SHARE 2022 (%)

FIGURE 326 KOREA VETERINARY MEDICINE MARKET: COMPANY SHARE 2022 (%)

FIGURE 327 VIETNAM VETERINARY MEDICINE MARKET: COMPANY SHARE 2022 (%)

FIGURE 328 THAILAND VETERINARY MEDICINE MARKET: COMPANY SHARE 2022 (%)

FIGURE 329 PHILIPPINES VETERINARY MEDICINE MARKET: COMPANY SHARE 2022 (%)

View Detailed Information Right Arrow

منهجية البحث

يتم جمع البيانات وتحليل سنة الأساس باستخدام وحدات جمع البيانات ذات أحجام العينات الكبيرة. تتضمن المرحلة الحصول على معلومات السوق أو البيانات ذات الصلة من خلال مصادر واستراتيجيات مختلفة. تتضمن فحص وتخطيط جميع البيانات المكتسبة من الماضي مسبقًا. كما تتضمن فحص التناقضات في المعلومات التي شوهدت عبر مصادر المعلومات المختلفة. يتم تحليل بيانات السوق وتقديرها باستخدام نماذج إحصائية ومتماسكة للسوق. كما أن تحليل حصة السوق وتحليل الاتجاهات الرئيسية هي عوامل النجاح الرئيسية في تقرير السوق. لمعرفة المزيد، يرجى طلب مكالمة محلل أو إرسال استفسارك.

منهجية البحث الرئيسية التي يستخدمها فريق بحث DBMR هي التثليث البيانات والتي تتضمن استخراج البيانات وتحليل تأثير متغيرات البيانات على السوق والتحقق الأولي (من قبل خبراء الصناعة). تتضمن نماذج البيانات شبكة تحديد موقف البائعين، وتحليل خط زمني للسوق، ونظرة عامة على السوق ودليل، وشبكة تحديد موقف الشركة، وتحليل براءات الاختراع، وتحليل التسعير، وتحليل حصة الشركة في السوق، ومعايير القياس، وتحليل حصة البائعين على المستوى العالمي مقابل الإقليمي. لمعرفة المزيد عن منهجية البحث، أرسل استفسارًا للتحدث إلى خبراء الصناعة لدينا.

التخصيص متاح

تعد Data Bridge Market Research رائدة في مجال البحوث التكوينية المتقدمة. ونحن نفخر بخدمة عملائنا الحاليين والجدد بالبيانات والتحليلات التي تتطابق مع هدفهم. ويمكن تخصيص التقرير ليشمل تحليل اتجاه الأسعار للعلامات التجارية المستهدفة وفهم السوق في بلدان إضافية (اطلب قائمة البلدان)، وبيانات نتائج التجارب السريرية، ومراجعة الأدبيات، وتحليل السوق المجدد وقاعدة المنتج. ويمكن تحليل تحليل السوق للمنافسين المستهدفين من التحليل القائم على التكنولوجيا إلى استراتيجيات محفظة السوق. ويمكننا إضافة عدد كبير من المنافسين الذين تحتاج إلى بيانات عنهم بالتنسيق وأسلوب البيانات الذي تبحث عنه. ويمكن لفريق المحللين لدينا أيضًا تزويدك بالبيانات في ملفات Excel الخام أو جداول البيانات المحورية (كتاب الحقائق) أو مساعدتك في إنشاء عروض تقديمية من مجموعات البيانات المتوفرة في التقرير.

Frequently Asked Questions

The Indonesia, Malaysia, Vietnam, Thailand, Philippines, Australia, New Zealand, China, Korea, and India Veterinary Medicine Market size will be worth USD 6,811.52 million by 2030.
The Indonesia, Malaysia, Vietnam, Thailand, Philippines, Australia, New Zealand, China, Korea, and India Veterinary Medicine Market growth rate will be 10.1% by 2030.
Increasing Pet Ownership and Humanization of Pets and Growing Prevalence of Animal Diseases are the growth drivers of the Indonesia, Malaysia, Vietnam, Thailand, Philippines, Australia, New Zealand, China, Korea, and India Veterinary Medicine Market.
The product, animal type, dosage, route of administration, application, end user, and distribution channel are the factors on which the Indonesia, Malaysia, Vietnam, Thailand, Philippines, Australia, New Zealand, China, Korea, and India Veterinary Medicine Market research is based.
The major companies in the Indonesia, Malaysia, Vietnam, Thailand, Philippines, Australia, New Zealand, China, Korea, and India Veterinary Medicine Market are Zoetis Services LLC (U.S.), Boehringer Ingelheim International GmbH.(Germany), Virbac (France), Ceva (France), Dechra Pharmaceuticals PLC (England), HUVEPHARMA (Bulgaria), Phibro Animal Health Corporation (U.S.), Kemin Industries, Inc.(U.S.), Vetoquinol (France), Mankind Pharma (India), Indian Immunologicals Ltd.(India), ECO Animal Health Ltd (U.K.), Biologische Heilmittel Heel GmbH, Alivira Animal Health Limited, Jurox Pty Limited, Biogénesis Bagó (Germany), Bentoli (U.S.), Inovet (Hungary), MSD Animal Health (U.S.), Zovix Pharmaceuticals (India), and Valor Chemical Co., Ltd (China).